Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/37290
Full metadata record
DC FieldValueLanguage
dc.contributor.editorDavies, Charlotteen_UK
dc.contributor.editorMurray, Rosemaryen_UK
dc.date.accessioned2025-08-02T00:16:17Z-
dc.date.available2025-08-02T00:16:17Z-
dc.date.issued2013-01-02en_UK
dc.identifier.urihttp://hdl.handle.net/1893/37290-
dc.description.abstractThe structure and content of this annual report are pre-determined by the EMCDDA to facilitate comparison with similar reports produced by the other European Focal Points. Ten chapters cover the same subjects each year. Each of the first ten chapters begins with an Introduction. This sets the context for the remainder of the chapter, describing the main features of the topic under consideration within the United Kingdom. This may include information about the main legislative and organisational frameworks, sources of data and definitions used, the broad picture shown by the data and recent trends. The remainder of each chapter is concerned with New Developments and Trends that have not been included in previous annual reports. Generally, this covers developments that have occurred in the second half of 2012 or the first half of 2013. Relevant data that have become available during this period will also be discussed although these will often refer to earlier time periods. This report, and the reports from the other European countries, will be used in the compilation of the EMCDDA’s annual report of the drug situation in the European Union and Norway to be published in 2014en_UK
dc.language.isoenen_UK
dc.relation(2013) <i>United Kingdom Drug Situation 2013 edition. UK Focal Point on Drugs annual report to the European Monitoring Centre for Drugs and Drug Abuse</i>. Davies C (Editor) & Murray R (Editor) European Monitoring Centre for Drugs and Drug Abuse. https://www.drugsandalcohol.ie/21074/1/UK_focalpointreport2013.pdfen_UK
dc.rights.urihttp://www.nationalarchives.gov.uk/doc/non-commercial-government-licence/version/2/en_UK
dc.titleUnited Kingdom Drug Situation 2013 edition. UK Focal Point on Drugs annual report to the European Monitoring Centre for Drugs and Drug Abuseen_UK
dc.typeTechnical Reporten_UK
dc.contributor.sponsorEuropean Monitoring Centre for Drugs and Drug Abuseen_UK
dc.citation.publicationstatusPublisheden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.contributor.funderPublic Health Englanden_UK
dc.identifier.urlhttps://www.drugsandalcohol.ie/21074/1/UK_focalpointreport2013.pdfen_UK
dc.author.emailrobyn.burton@stir.ac.uken_UK
dc.citation.date02/01/2013en_UK
dc.contributor.affiliationInstitute for Social Marketingen_UK
dc.identifier.wtid2063386en_UK
dc.contributor.orcid0000-0003-1684-5238en_UK
dcterms.dateAccepted2013-01-02en_UK
dc.date.filedepositdate2025-07-07en_UK
rioxxterms.apcnot chargeden_UK
rioxxterms.typeTechnical Reporten_UK
rioxxterms.versionVoRen_UK
local.rioxx.projectProject ID unknown|Public Health England|http://dx.doi.org/10.13039/501100002141en_UK
local.rioxx.contributorDavies, Charlotte|0000-0003-1684-5238en_UK
local.rioxx.contributorMurray, Rosemary|en_UK
local.rioxx.freetoreaddate2025-07-24en_UK
local.rioxx.licencehttp://www.nationalarchives.gov.uk/doc/non-commercial-government-licence/version/2/|2025-07-24|en_UK
local.rioxx.filenameUK_focalpointreport2013.pdfen_UK
local.rioxx.filecount1en_UK
Appears in Collections:Faculty of Health Sciences and Sport Technical Reports

Files in This Item:
File Description SizeFormat 
UK_focalpointreport2013.pdfFulltext - Published Version3.9 MBAdobe PDFView/Open


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.